Glaukos Corp (GKOS)
144.53
+3.70
(+2.63%)
USD |
NYSE |
Nov 22, 11:33
Glaukos Total Liabilities (Quarterly): 258.03M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 258.03M |
| June 30, 2024 | 254.52M |
| March 31, 2024 | 482.61M |
| December 31, 2023 | 478.65M |
| September 30, 2023 | 470.98M |
| June 30, 2023 | 467.93M |
| March 31, 2023 | 464.08M |
| December 31, 2022 | 472.38M |
| September 30, 2022 | 459.91M |
| June 30, 2022 | 468.80M |
| March 31, 2022 | 454.51M |
| December 31, 2021 | 462.55M |
| September 30, 2021 | 463.08M |
| June 30, 2021 | 459.40M |
| March 31, 2021 | 433.00M |
| December 31, 2020 | 338.05M |
| September 30, 2020 | 332.95M |
| June 30, 2020 | 333.31M |
| March 31, 2020 | 138.42M |
| December 31, 2019 | 145.13M |
| Date | Value |
|---|---|
| September 30, 2019 | 117.32M |
| June 30, 2019 | 114.28M |
| March 31, 2019 | 42.55M |
| December 31, 2018 | 33.11M |
| September 30, 2018 | 27.09M |
| June 30, 2018 | 22.56M |
| March 31, 2018 | 20.33M |
| December 31, 2017 | 27.63M |
| September 30, 2017 | 20.51M |
| June 30, 2017 | 19.59M |
| March 31, 2017 | 14.95M |
| December 31, 2016 | 17.10M |
| September 30, 2016 | 19.05M |
| June 30, 2016 | 18.96M |
| March 31, 2016 | 18.26M |
| December 31, 2015 | 21.47M |
| September 30, 2015 | 22.91M |
| June 30, 2015 | 33.38M |
| March 31, 2015 | 32.22M |
| December 31, 2014 | 186.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
138.42M
Minimum
Mar 2020
482.61M
Maximum
Mar 2024
391.91M
Average
459.66M
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| Baxter International Inc | 18.73B |
| Masimo Corp | 1.625B |
| Teleflex Inc | 3.005B |
| Perspective Therapeutics Inc | 62.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 926.54M |
| Shareholders Equity (Quarterly) | 668.51M |
| Debt to Equity Ratio | 0.0849 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.63% |